0001437749-22-021457.txt : 20220829
0001437749-22-021457.hdr.sgml : 20220829
20220829164535
ACCESSION NUMBER: 0001437749-22-021457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220113
FILED AS OF DATE: 20220829
DATE AS OF CHANGE: 20220829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guirakhoo Farshad
CENTRAL INDEX KEY: 0001656602
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 221211737
MAIL ADDRESS:
STREET 1: 39 CHESTNUT STREET
CITY: MELROSE
STATE: MA
ZIP: 02176
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-01-13
1
0001851657
Vaxxinity, Inc.
VAXX
0001656602
Guirakhoo Farshad
1717 MAIN STREET
SUITE 3388
DALLAS
TX
75201
1
(Former) Chief Scientific Off.
Class A common stock
2022-01-13
4
M
0
10000
0.57
A
10000
D
Class A common stock
2022-07-29
4
M
0
20000
0.57
A
40000
D
Class A common stock
2022-08-15
4
M
0
26005
0.57
A
66005
D
Class A common stock
2022-08-22
4
M
0
2640
0.57
A
68645
D
Stock option (right to buy)
0.57
2022-01-13
4
M
0
10000
0
D
2021-06-05
2031-03-01
Class A common stock
10000
116730
D
Stock option (right to buy)
0.57
2022-07-29
4
M
0
20000
0
D
2021-06-05
2031-03-01
Class A common stock
20000
86730
D
Stock option (right to buy)
0.57
2022-08-15
4
M
0
26005
0
D
2021-06-05
2031-03-01
Class A common stock
26005
60725
D
Stock option (right to buy)
0.57
2022-08-22
4
M
0
2640
0
D
2021-06-05
2031-03-01
Class A common stock
2640
58085
D
The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 10,000 shares of Class A common stock after the transaction on May 3, 2022 but the Reporting Person then owned 20,000 shares of Class A common stock.
These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period.
The Reporting Person's Form 4 filed on May 5, 2022 incorrectly reported that the Reporting Person owned 116,730 of these stock options after the transaction on May 3, 2022 but the Reporting Person then owned 106,730 of these stock options.
/s/ Rene Paula Molina, attorney-in-fact for Farshad Guirakhoo
2022-08-29